Hemostemix's Boots on the Ground in Florida October Update @hemostemix #2VF0 #ACP01 #HEARTREPAIRGUY #HEM #HMTXF #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing
Calgary, Alberta--(Newsfile Corp. - October 30, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from pain related to angina, peripheral arterial disease, chronic limb threatening ischemia, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, today announced major progress in Florida as it builds...
http://dlvr.it/TNzD6w
http://dlvr.it/TNzD6w
Comments
Post a Comment